Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Hisato, Hara"'
Autor:
Keita Sasaki, Junki Mizusawa, Hiroko Bando, Kenichi Nakamura, Tomoko Kataoka, Hiroshi Katayama, Haruhiko Fukuda, Hisato Hara
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Poor patient accrual can delay reporting of clinical trials and, consequently, the development of new treatments. For reducing the risk of additional resource requirements, a method for setting planned accrual periods with minimal
Externí odkaz:
https://doaj.org/article/119968e2b2564c9e966ec6c41f0fc6c8
Autor:
Yurina Yanase, Hiroko Bando, Riko Sato, Tomohei Matsuo, Aya Ueda, Mai Okazaki, Sachie Hashimoto, Akiko Iguchi-Manaka, Hisato Hara
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-6 (2024)
Abstract Background As an oncologic emergency related to abnormalities in calcium metabolism, hypercalcemia associated with paraneoplastic syndrome and bone metastases is well known. Meanwhile, the incidence of hypocalcemia is low, except in cases as
Externí odkaz:
https://doaj.org/article/104e13d3f2af49b1a6904635dfa4ea2e
Autor:
Azusa Terasaki, Hiroko Bando, Aya Ueda, Mai Okazaki, Sachie Hashimoto, Akiko Iguchi-Manaka, Yuzuru Kondo, Hisato Hara
Publikováno v:
International Cancer Conference Journal. 12:143-148
Autor:
Hiroki Matsumura, Larina Tzu-Wei Shen, Akihiro Isozaki, Hideharu Mikami, Dan Yuan, Taichi Miura, Yuto Kondo, Tomoko Mori, Yoshika Kusumoto, Masako Nishikawa, Atsushi Yasumoto, Aya Ueda, Hiroko Bando, Hisato Hara, Yuhong Liu, Yunjie Deng, Masahiro Sonoshita, Yutaka Yatomi, Keisuke Goda, Satoshi Matsusaka
Publikováno v:
Lab on a Chip. 23:1561-1575
Heterogeneous clusters of cancer cells and leukocytes in blood were visualized by combining high-throughput and high-sensitivity fluorescence imaging flow cytometry with 5-aminolevulinic acid stimulation.
Autor:
Takuya Higashiyama, Kiminori Sugino, Hisato Hara, Ken-ichi Ito, Noriaki Nakashima, Naoyoshi Onoda, Masayuki Tori, Hiroshi Katoh, Naomi Kiyota, Ichiro Ota, Nobuyasu Suganuma, Yatsuka Hibi, Toshimitsu Nemoto, Shunji Takahashi, Katsunari Yane, Tetsuya Ioji, Shinsuke Kojima, Hideaki Kaneda, Iwao Sugitani, Makoto Tahara
Publikováno v:
European Journal of Cancer. 173:210-218
Anaplastic thyroid cancer (ATC) is a rare and highly aggressive cancer for which effective systemic therapy has long been sought. Here, we assessed the efficacy and safety of lenvatinib in patients with unresectable ATC.The study was investigator-ini
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 83:832-837
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 83:257-262
Autor:
Aya Ueda, Yukiko Tsushima, Rio Asada, Emika Ichioka, Yuzuru Kondo, Hisato Hara, Hiroko Bando, Mai Okazaki, Akiko Iguchi-Manaka
Publikováno v:
Choonpa Igaku. 48:293-297
Autor:
Aya Sawa, Hiroko Bando, Reina Kamohara, Naoto Takeuchi, Azusa Terasaki, Mai Okazaki, Akiko Iguchi-Manaka, Hisato Hara
Publikováno v:
Oncology. 100(11)
Introduction: Recently, absolute lymphocyte count (ALC) and neutrophil-to-lymphocyte ratio (NLR) have been reported to be prognostic and/or predictive factors in breast cancer. However, most of the investigations on the relationship between systemic
Autor:
Tatsuhiko Ikeda, Kiyo-aki Ishii, Yuria Saito, Masahiro Miura, Aoi Otagiri, Yasushi Kawakami, Hitoshi Shimano, Hisato Hara, Kazuhiro Takekoshi
Publikováno v:
Journal of Pharmacological Sciences, Vol 121, Iss 1, Pp 67-73 (2013)
Sunitinib is an oral multitargeted receptor tyrosine kinase inhibitor with antiangiogenic and antitumor activity that mainly targets vascular endothelial growth factor receptors, and recently, it has been shown to be an active agent for the treatment
Externí odkaz:
https://doaj.org/article/c6cfc70e03d3455793582f01f8afb7fe